Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BioLineRx's CXCR4 Antagonist: Promising For Stem Cell Mobilization And AML

Dec 05 2017

• By John Davis

AML — • Source: Shutterstock

Related Companies

BioLineRx Ltd.

Sanofi

Eli Lilly and Company

Bristol Myers Squibb Company

X4 Pharmaceuticals, Inc.

TaiGen Biotechnology Co., Ltd.

Polyphor AG

Sawai Pharmaceutical Co., Ltd.

GlycoMimetics, Inc.

Pfizer Inc.

Genentech, Inc.

Biokine Therapeutics Ltd.

Merck & Co., Inc.

Roche Holding AG

Additional Topics

Clinical Trials Research & Development ImmunoOncology Cancer BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.